Anisha Dua
@anisha_dua
Program Director of Rheumatology @NorthwesternMed. Interested in #MedEd and #vasculitis. Views are my own.
Register for the next ACR Convergence Replay recorded webinar—Controversies in the Treatment of ANCA-Associated Vasculitis—April 15, 7:00-8:15 PM ET. Live speaker Q&A post-session where you can ask questions & get further insights!
A study by Laura C. Arneson, MD (@LauraArneson4), and Brian D. Jaros, MD (@Dr_Brian_MD), examined various factors contributing to physician burnout, highlighting the link between EMR message volume and burnout. Read more: breakthroughsforphysicians.nm.org/rheumatology-r…
Congratulations to our very own Brian Jaros, MD (@Dr_Brian_MD), recipient of @ACRheum’s 2024 Distinguished Fellow Award, presented during #ACR24 in Washington, DC. Congratulations, Dr. Jaros! rheumatology.org/acr-awards
Honored to have been named an ACR distinguished fellow amongst this group of amazing individuals! Shoutout to my mentors, especially @anisha_dua who have guided my rheum journey and thank you to @ACRheum #ACR24 Congrats to all this year’s awardees!
Rct of > 200 patients with knee OA treated with usual care plus mtx vs pbo. Mtx titrated to 25mg weekly and showed improvement in pain score c/w PBO at 6 months w/o significant AEs! @Tuhina_Neogi @AM_Malf —will this change OA management?


Quick plug for a new rheumatology conference! Great city at a great time of the year. I'll be there moderating and giving a few talks myself Come join and say hello! rheumtechsympo.com
✅ Very happy to share with you the link to our latest @Nature Review #Rheumatology on relapsing #polychondritis ⬇️ With @MertzP et Coll., we dig deep into the main differential diagnoses, including #VEXAS 👍 Read only at the following LINK:rdcu.be/dGxy6
Interesting study in the evolving role of sglt2 inhibition in gout in @JAMAInternalMed ♥️ rheum overlap


Today was an inspiring day at the @ACRheum Educator’s Conference in #Chicago.🌟Let’s shape the future of #Rheumatology #MedEd together!💡
🚨 New activity with @LCalabreseDO, @AdamJBrownMD, @anisha_dua, @MdWarrington & David Jayne, MD available now for 1.25 #CME credits >> ow.ly/ha9t50QrTNs
This #CME podcast led by @LCalabreseDO & @anisha_dua features a discussion on the use of immunosuppressants and corticosteroids for the induction and maintenance of EGPA remission >> ow.ly/HVUh50OXhs1
Check out our recent publication on suspected #polymyalgia #rheumatica ▶️ early referral ▶️ clinical examination ▶️ role of primary care ▶️ glucocorticoids 🔗 bit.ly/3NfA0PD @cmukhtyar @Sarah_L_Mackie @SattuiSEMD @anisha_dua @cristinadbponte @VictorioPQ @drceowen
🔔Mentor member meeting with @EMEUNET are a fantastic way to meet rheumatologist from around the world, and learn from both experts & peers 🔔 Join us online on 20th & 22nd Nov for the #ACR23 edition 🔔Email: [email protected] with your name, country, preferred date
Join us Monday, 11/13 at 6:30 PM PT for this #CME dinner during #ACR23. Drs. @LCalabreseDO @MdWarrington @Anisha_Dua @AdamJBrownMD & David Jayne will discuss the complexities of ANCA-Associated Vasculitis >> ow.ly/sf7B50PQ8Tp #rheumatology #rheumtwitter @MarriottMarina
Glad to share our latest @MassGenBrigham Rheum COVID-19 paper, led by Emily Kowalski @zach_wallace_md Risk factors and outcomes for repeat COVID-19 infection among patients with systemic autoimmune rheumatic diseases: A case-control study sciencedirect.com/science/articl…
NEW RESEARCH—Sebastian Unizony and colleagues report the results of a single-arm, open-label, proof-of-concept study of 8 weeks of #prednisone in combination with #tocilizumab for treatment for giant cell arteritis #GCA thelancet.com/journals/lanrh…
🎧 Listen, learn, & earn #CME with this podcast series, featuring expert insight from @LCalabreseDO , @AdamJBrownMD , @anisha_dua & @ebrheum >> ow.ly/HVUh50OXhs1
#PMR: Is There Hidden GCA? Dr. Anisha Dua, asks the question: in PMR should you worry about occult GCA? bit.ly/3RUU5hi @anisha_dua
Had a great time having this important conversation!
TNR: #PMR Diagnosis and Monitoring Tuesday Night Rheumatology webinar on the diagnosis and monitoring of PMR. Featuring Panelists, Drs. Claire Owen, Anisha Dua, Stephen Paget and moderated by Jack Cush. bit.ly/45rkjeE @anisha_dua @Rheummd @drceowen
Awesome to have an option for refractory PMR. Active sx on pred >7.5. Sarilumab with 24 wk pred vs 52 week pred taper— ⬆️sustained remission and ⬇️GCs ⬆️arthralgia, neutropenia and diarrhea in sarilumab @HSpecialSurgery @RheumNow @VasculitisFound
